Cell membrane gp96 facilitates HER2 dimerization and serves as a novel target in breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cell membrane gp96 facilitates HER2 dimerization and serves as a novel target in breast cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 137, Issue 3, Pages 512-524
Publisher
Wiley
Online
2014-12-27
DOI
10.1002/ijc.29405
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interaction between Her2 and Beclin-1 Proteins Underlies a New Mechanism of Reciprocal Regulation
- (2013) Jie Han et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2
- (2013) Pallav D Patel et al. Nature Chemical Biology
- The role of glycoprotein 96 in the persistent inflammation of rheumatoid arthritis
- (2012) Qi-Quan Huang et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: Implications for tumor recurrence
- (2012) Nicolas Dejeans et al. FREE RADICAL BIOLOGY AND MEDICINE
- Listeria monocytogenesTriggers the Cell Surface Expression of Gp96 Protein and Interacts with Its N Terminus to Support Cellular Infection
- (2012) Mariana Martins et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Proteomic Plasma Membrane Profiling Reveals an Essential Role for gp96 in the Cell Surface Expression of LDLR Family Members, Including the LDL Receptor and LRP6
- (2012) Michael P. Weekes et al. JOURNAL OF PROTEOME RESEARCH
- A single ligand is sufficient to activate EGFR dimers
- (2012) P. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TAT-mediated gp96 transduction to APCs enhances gp96-induced antiviral and antitumor T cell responses
- (2012) Bao Zhao et al. VACCINE
- Expression of Endoplasmic Reticulum Stress Proteins Is a Candidate Marker of Brain Metastasis in both ErbB-2+ and ErbB-2− Primary Breast Tumors
- (2011) Rebeca Sanz-Pamplona et al. AMERICAN JOURNAL OF PATHOLOGY
- Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers
- (2011) R. Ghosh et al. CANCER RESEARCH
- Differential action of small molecule HER kinase inhibitors on receptor heterodimerization: Therapeutic implications
- (2011) M. Sánchez-Martín et al. INTERNATIONAL JOURNAL OF CANCER
- A strategy to produce monoclonal antibodies against gp96 by prime-boost regimen using endogenous protein and E. coli heterologously-expressed fragment
- (2011) Yu-dan Zhang et al. JOURNAL OF CENTRAL SOUTH UNIVERSITY OF TECHNOLOGY
- Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- gp96 expression in neutrophils is critical for the onset of Escherichia coli K1 (RS218) meningitis
- (2011) Rahul Mittal et al. Nature Communications
- Toll-like receptor 4-mediated c-Jun N-terminal kinase activation induces gp96 cell surface expression via AIMP1 phosphorylation
- (2010) Gyuyoup Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
- (2010) SaeGwang Park et al. CANCER CELL
- Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
- (2010) J. R. Junutula et al. CLINICAL CANCER RESEARCH
- Biological considerations and clinical applications of new HER2-targeted agents
- (2010) Gerald M Higa et al. Expert Review of Anticancer Therapy
- Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion
- (2010) N. Rolhion et al. GUT
- Carbamazepine promotes Her-2 protein degradation in breast cancer cells by modulating HDAC6 activity and acetylation of Hsp90
- (2010) Qingwei Meng et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Spatial control of EGF receptor activation by reversible dimerization on living cells
- (2010) Inhee Chung et al. NATURE
- A novel interaction between HER2/neu and cyclin E in breast cancer
- (2010) E A Mittendorf et al. ONCOGENE
- Identification of gp96 as a Novel Target for Treatment of Autoimmune Disease in Mice
- (2010) Jung Min Han et al. PLoS One
- Cell-surface Processing of the Metalloprotease Pro-ADAMTS9 Is Influenced by the Chaperone GRP94/gp96
- (2009) Bon-Hun Koo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Chaperone Activity of GRP94 Toward Insulin-like Growth Factor II Is Necessary for the Stress Response to Serum Deprivation
- (2009) Olga Ostrovsky et al. MOLECULAR BIOLOGY OF THE CELL
- Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2-positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib
- (2009) C. C. Leow et al. MOLECULAR CANCER THERAPEUTICS
- ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor
- (2009) Diego Alvarado et al. NATURE
- Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models
- (2009) E. Caldas-Lopes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endoplasmic reticulum HSP90b1 (gp96, grp94) optimizes B-cell function via chaperoning integrin and TLR but not immunoglobulin
- (2008) B. Liu et al. BLOOD
- SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase Dependent Cancers
- (2008) S. Chandarlapaty et al. CLINICAL CANCER RESEARCH
- Endocytosis and intracellular trafficking of ErbBs
- (2008) Alexander Sorkin et al. EXPERIMENTAL CELL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search